STRD vs TECH
MicroStrategy Incorporated 10.00% Series A Perpetual Stride Preferred Stock (STRD) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
MicroStrategy Incorporated 10.00% Series A Perpetual Stride Preferred Stock (STRD) is a software - application company listed on NASDAQ.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported STRD revenue for 2024-12-31 was $463.5M. Net income was -$1.17B. Revenue was down 6.6% from 2023-12-31 to 2024-12-31. STRD currently screens at market cap $901.8M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
STRD currently screens at market cap $901.8M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the STRD and TECH stock pages for the full models.
Not investment advice.